Sapiens International Corp. N.V. (SPNS) Jumps 8.73% on February 17

Equities Staff |

Sapiens International Corp. N.V. (SPNS) was among the biggest gainers on the Russell 2000 for Wednesday February 17 as the stock popped 8.73% to $10.96, representing a gain of $0.88 per share. Some 67,294 shares traded hands on 505 trades, compared with an average daily volume of 74,566 shares out of a total float of 47.93 million. The stock opened at $10.53 and traded with an intraday range of $11.01 to $10.53.

After today's gains, Sapiens International Corp. N.V. reached a market cap of $525.33 million. Sapiens International Corp. N.V. has had a trading range between $12.72 and $6.94 over the last year, and it had a 50-day SMA of $9.90 and a 200-day SMA of $10.53.

The stock has a P/E Ratio of 27.2.

Sapiens International Corp is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector.

Sapiens International Corp. N.V. is based out of Curaçao, and has some 1,017 employees. Its CEO is Ron Al Dor.

For a complete fundamental analysis analysis of Sapiens International Corp. N.V., check out’s Stock Valuation Analysis report for SPNS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…